Aravas Inc.

Langhorne, PA Doing business as Savara Inc.

UEI
HDD4ZCLWT1K6
CAGE
4TJP3
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1717 Langhorne Newtown Rd #300, Langhorne, PA 19047, USA
Website
savarapharma.com
Founded
2007
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Targeted nanoparticle gene therapy for lung cancer U43CA165462 National Institutes of Health $190,353
Development of inhaled vancomycin for treatment of mrsa infections in CF R44HL112393 National Institutes of Health $3,986,098
Development of inhaled vancomycin for treatment of mrsa infections in CF R43HL112393 National Institutes of Health $149,750
A high efficiency corticosteroid dry powder inhaler for pediatric use R43AI092973 National Institutes of Health $184,148

Quick answers

Is Aravas Inc. registered in SAM.gov?

Yes. Aravas Inc.'s SAM.gov registration is active through April 17, 2027.

What is Aravas Inc.'s most recent federal award?

Aravas Inc.'s most recent federal grant award is Targeted nanoparticle gene therapy for lung cancer (U43CA165462), from National Institutes of Health, on July 1, 2013.

On GovTribe

See Aravas Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login